JPML Eyes Gadolinium Contrast Agent Cases
A representative for the MDL panel confirmed Thursday that it had received a motion to transfer cases involving product liability claims against the makers of gadolinium-based contrast agents used in MRI testing. The panel has started the process that may lead to the docketing of the MDL case.
Suits against contrast...
To view the full article, register now.